We & Win Diversification Co., Ltd. (TPEX: 4113)

Market Cap	7.50B
Revenue (ttm)	4.65B
Net Income (ttm)	678.35M
Shares Out	231.14M
EPS (ttm)	3.20
PE Ratio	10.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	894,202
Open	29.45
Previous Close	29.20
Day's Range	28.90 - 29.75
52-Week Range	26.85 - 68.50
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About We & Win Diversification

We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung City, Taiwan.

• Industry: Engineering & Construction
• Sector: Industrials
• Founded: 1987
• Employees: 35
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4113

Financial Performance

In 2023, We & Win Diversification's revenue was 518.06 million, an increase of 498.68% compared to the previous year's 86.53 million. Losses were -145.73 million, 1.06% more than in 2022.